SCHEMBL5798930

SCHEMBL5798930

CON=C(C)C(Cc1ccc(O)cc1)C(=O)OC

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.54
ESR2 Q92731 2/20 0.54
MIF P14174 3/20 0.50
PTPRB P23467 1/20 0.46
KMT2A Q03164 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
TSHR P16473 1/20 0.41
LNPEP Q9UIQ6 1/20 0.41
MDM4 O15151 1/20 0.41
MDM2 Q00987 1/20 0.41
SLC7A5 Q01650 1/20 0.41
PPARG P37231 4/20 0.41
PPARA Q07869 4/20 0.41
PPARD Q03181 3/20 0.41
LDHA P00338 1/20 0.41
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5798926 1.00 ESR1 (0.54) ESR1ESR2MIFPTPRBKMT2A
SCHEMBL6510040 0.87 ESR1 (0.50) ESR1ESR2MIFPTPRBKMT2A
SCHEMBL6507417 0.87 ESR1 (0.50) ESR1ESR2MIFPTPRBKMT2A
SCHEMBL6507933 0.87 ESR1 (0.50) ESR1ESR2MIFPTPRBKMT2A
SCHEMBL6507419 0.87 ESR1 (0.50) ESR1ESR2MIFPTPRBKMT2A
SCHEMBL6511074 0.85 ESR1 (0.48) ESR1ESR2MIFPTPRBKMT2A
SCHEMBL6508785 0.85 MIF (0.48) ESR1ESR2MIFPTPRBKMT2A
SCHEMBL6511070 0.85 ESR1 (0.48) ESR1ESR2MIFPTPRBKMT2A
SCHEMBL6510326 0.85 MIF (0.48) ESR1ESR2MIFPTPRBKMT2A
SCHEMBL6380182 0.84 ESR1 (0.67) ESR1ESR2MIFPTPRBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006057505-A1 NOVEL COMPOUNDS AS AGONIST FOR PPARϜ AND PPARα, METHOD FOR PREPARATION OF THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME LG LIFE SCIENCES, LTD. (KR) 2006-06-01 WO disclosed
WO-2005040127-A1 NOVEL COMPOUNDS AS AGONIST FOR PPAR GAMMA AND PPAR ALPHA, METHOD FOR PREPARATION OF THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME LG LIFE SCIENCES LTD. (KR) 2005-05-06 WO disclosed